Loading clinical trials...

A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci | Clinical Trials | Clareo Health

COMPLETED

A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci

NCT01040143•Public Health England

View on ClinicalTrials.gov

Summary

A study taking swabs from the back of the nose (nasopharynx) to look at carriage of pneumococci.

Eligibility

Age

1 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Born in a cohort eligible for routine or catch up pneumococcal conjugate vaccination (i.e. date of birth since 4th September 2004) or a family member where a child is eligible and has been enrolled
•Written informed consent given by the subject's parent/ legal guardian as well as assent from the child after the nature of the study has been explained to them or
•Written informed consent given by the subject after the nature of the study has been explained to them

Exclusion Criteria

•Moderate to severe disability.
•Cerebral palsy, syndromes and neurological disorders affecting swallowing.
•Ear Nose and Throat disorders affecting the anatomy of the ear,i.e.malformed ears.
•Confirmed or suspected immunodeficiency (congenital or acquired).
•On immunosuppressive therapy.

Locations (3)

Health Protection Agency

Stevenage, Hertfordshire, United Kingdom

Health Protection Agency

Gloucester, United Kingdom

Health Protection Agency

London, United Kingdom

Key Dates

Start Date

January 1, 2008

Primary Completion Date

March 1, 2010

Completion Date

March 1, 2010

Last Updated

March 22, 2019

Enrollment

450

ESTIMATED participants

Conditions

Pneumococcal Disease

Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15

NCT06731374

Pneumococcal DiseasePneumococcal Carriage

View study

RECRUITINGPHASE3

A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People

NCT06044077

Pneumococcal Disease

View study

ACTIVE_NOT_RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 22, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci

Inclusion Criteria

Exclusion Criteria

Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15

A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)

A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan